Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 12
Submit an article Journal homepage
393
Views
44
CrossRef citations to date
0
Altmetric
Drug Evaluation

GVAX: an allogeneic, whole-cell, GM-CSF-secreting cellular immunotherapy for the treatment of prostate cancer

James E Ward Internal Medicine Resident University of Wisconsin, Department of Medicine, Madison, WI 53792, USA
, MD &
Douglas G McNeel Associate Professor of Medicine University of Wisconsin Paul P Carbone Comprehensive Cancer Center, K4/518 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA +1 608 265 8131; +1 608 265 8133; [email protected]
, MD PhD
Pages 1893-1902 | Published online: 22 Nov 2007

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Aijaz Parray, Hifzur R Siddique, Sanjeev Nanda, Badrinath R Konety & Mohammad Saleem. (2012) Castration-resistant prostate cancer: potential targets and therapies. Biologics: Targets and Therapy 6, pages 267-276.
Read now
Mark Tangney, Sarfraz Ahmad, Sara A. Collins & Gerald C. O'Sullivan. (2010) Gene Therapy for Prostate Cancer. Postgraduate Medicine 122:3, pages 166-180.
Read now
Ravi A Madan, Mahsa Mohebtash, Jeffrey Schlom & James L Gulley. (2010) Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opinion on Biological Therapy 10:1, pages 19-28.
Read now

Articles from other publishers (41)

Manish Malviya, Zita E. H. Aretz, Zaki Molvi, Jayop Lee, Stephanie Pierre, Patrick Wallisch, Tao Dao & David A. Scheinberg. (2023) Challenges and solutions for therapeutic TCR ‐based agents . Immunological Reviews 320:1, pages 58-82.
Crossref
Ichwaku Rastogi, Anusha Muralidhar & Douglas G. McNeel. (2023) Vaccines as treatments for prostate cancer. Nature Reviews Urology.
Crossref
Bruno Bockorny, Joseph E. Grossman & Manuel Hidalgo. (2022) Facts and Hopes in Immunotherapy of Pancreatic Cancer. Clinical Cancer Research 28:21, pages 4606-4617.
Crossref
Shiqi Huang, Yining Zhu, Ling Zhang & Zhirong Zhang. (2022) Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Advanced Materials 34:46, pages 2107946.
Crossref
Jeffrey Schlom, Sofia R. Gameiro, Claudia Palena & James L. Gulley. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 8 .
Brigida Anna Maiorano, Giovanni Schinzari, Davide Ciardiello, Maria Grazia Rodriquenz, Antonio Cisternino, Giampaolo Tortora & Evaristo Maiello. (2021) Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities. Vaccines 9:6, pages 623.
Crossref
Melissa Gamat-Huber, Donghwan Jeon, Laura E. Johnson, Jena E. Moseman, Anusha Muralidhar, Hemanth K. Potluri, Ichwaku Rastogi, Ellen Wargowski, Christopher D. Zahm & Douglas G. McNeel. (2020) Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC). Cancers 12:10, pages 2831.
Crossref
Thomas J. Gardner, Christopher M. Bourne, Megan M. Dacek, Keifer Kurtz, Manish Malviya, Leila Peraro, Pedro C. Silberman, Kristen C. Vogt, Mildred J. Unti, Renier Brentjens & David Scheinberg. (2020) Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery. Cancers 12:8, pages 2175.
Crossref
Douglas G. McNeel. (2017) Therapeutic Cancer Vaccines: How Much Closer Are We?. BioDrugs 32:1, pages 1-7.
Crossref
Christopher D. Zahm, Viswa Teja Colluru & Douglas G. McNeel. (2017) DNA vaccines for prostate cancer. Pharmacology & Therapeutics 174, pages 27-42.
Crossref
Jeffery Schlom, James L. Gulley & James W. Hodge. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine 1 22 .
Joaquim Bellmunt & Irene Moreno. 2017. Management of Prostate Cancer. Management of Prostate Cancer 357 377 .
Hongwei Tian, Gang Shi, Qin Wang, Yiming Li, Qianmei Yang, Chunlei Li, Guoyou Yang, Min Wu, Qian Xie, Shuang Zhang, Yang Yang, Rong Xiang, Dechao Yu, Yuquan Wei & Hongxin Deng. (2016) A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity. Signal Transduction and Targeted Therapy 1:1.
Crossref
Scott B. LovitchScott J. Rodig. (2016) The Role of Surgical Pathology in Guiding Cancer Immunotherapy. Annual Review of Pathology: Mechanisms of Disease 11:1, pages 313-341.
Crossref
Ming Li, Shuangyin Han & Xiwen Shi. (2015) In situ dendritic cell vaccination for the treatment of glioma and literature review. Tumor Biology 37:2, pages 1797-1801.
Crossref
Ming Li, Bin Wang, Zhonghua Wu, Jiadong Zhang, Xiwen Shi, Wenlan Cheng & Shuangyin Han. (2015) A novel recombinant protein of ephrinA1–PE38/GM-CSF activate dendritic cells vaccine in rats with glioma. Tumor Biology 36:7, pages 5497-5503.
Crossref
Brian Wan-Chi Tse, Lidija Jovanovic, Colleen Coyne Nelson, Paul de Souza, Carl Andrew Power & Pamela Joan Russell. (2014) From Bench to Bedside: Immunotherapy for Prostate Cancer. BioMed Research International 2014, pages 1-11.
Crossref
Ravi A. Madan, Theresa A. Ferrara & James L. Gulley. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 553 568 .
Anna Kozłowska, Jacek Mackiewicz & Andrzej Mackiewicz. (2013) Therapeutic gene modified cell based cancer vaccines. Gene 525:2, pages 200-207.
Crossref
Archana Thakur, Ulka Vaishampayan & Lawrence Lum. (2013) Immunotherapy and Immune Evasion in Prostate Cancer. Cancers 5:4, pages 569-590.
Crossref
Marijo Bilusic, Ravi A. Madan & James L. Gulley. 2013. Cancer Immunotherapy. Cancer Immunotherapy 455 474 .
Philip Kantoff & Celestia S. Higano. (2012) Integration of immunotherapy into the management of advanced prostate cancer. Urologic Oncology: Seminars and Original Investigations 30:5, pages S41-S47.
Crossref
Laura Mansi, Antoine Thiery-Vuillemin, Elsa Kalbacher, Thierry Nguyen, Tristan Maurina, Jérémie Nallet, Stefano Kim, Christophe Borg, François Kleinclauss, Xavier Pivot & Olivier Adotevi. (2012) L’immunothérapie : une nouvelle approche dans la prise en charge du cancer de prostate résistant à la castration. Bulletin du Cancer 99:1, pages S57-S65.
Crossref
Emmanuel S. Antonarakis, Michael A. Carducci & Mario A. Eisenberger. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology 2954 2971.e4 .
Stuart M. Flechner,James H. Finke,Robert L. Fairchild,. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology 495 529.e5 .
Marijo Bilusic & James L. Gulley. (2011) Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines. Cancer Immunology, Immunotherapy 61:1, pages 109-117.
Crossref
J. Bedke, C. Gouttefangeas & A. Stenzl. (2011) ProstatakarzinomProstate carcinoma. Der Urologe 51:1, pages 44-49.
Crossref
Edward ChaLawrence Fong. (2011) Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches. Journal of Clinical Oncology 29:27, pages 3677-3685.
Crossref
C. Nabhan, B. Parsons, E.Z. Touloukian & W.M. Stadler. (2011) Novel approaches and future directions in castration-resistant prostate cancer. Annals of Oncology 22:9, pages 1948-1957.
Crossref
Marijo Bilusic, Christopher Heery & Ravi A. Madan. (2011) Immunotherapy in prostate cancer: Emerging strategies against a formidable foe. Vaccine 29:38, pages 6485-6497.
Crossref
Kosuke Mizutani, Russell S. Taichman & Kenneth J. Pienta. 2012. Cancer Metastasis. Cancer Metastasis 456 464 .
Anne Clavreul, Nicole Piard, Jean-Yves Tanguy, Eric Gamelin, Marie-Christine Rousselet, Pierre Leynia & Philippe Menei. (2010) Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas. Journal of Clinical Neuroscience 17:7, pages 842-848.
Crossref
Emmanuel S. Antonarakis, Michael A. Carducci & Mario A. Eisenberger. (2010) Novel targeted therapeutics for metastatic castration-resistant prostate cancer. Cancer Letters 291:1, pages 1-13.
Crossref
Ravi A. Madan, James L. Gulley, Jackie Celestin, Philip M. Arlen & Jeffrey Schlom. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer 305 319 .
Alban Gervais, Jean-Christophe Eymard, Eric Toulmonde & Jacky Bernard. (2009) Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro. Cancer Immunology, Immunotherapy 58:11, pages 1831-1841.
Crossref
Therese Buskas, Pamela Thompson & Geert‐Jan Boons. 2009. Carbohydrate‐Based Vaccines and Immunotherapies. Carbohydrate‐Based Vaccines and Immunotherapies 263 311 .
Yoshifumi Kawaguchi, Yasuhide Miyamoto, Takehiro Inoue & Yasufumi Kaneda. (2009) Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle. International Journal of Cancer 124:10, pages 2478-2487.
Crossref
Raj A. Persad & Amit Bahl. (2009) Modern Chemotherapy Strategies for Management of ‘Hormone Resistant Prostate Cancer’ (HRPC)—When Should the Urologist Refer?. British Journal of Medical and Surgical Urology 2:3, pages 92-99.
Crossref
Min Wang, Ryan S. Senger, Carlos Paredes, Gautam G. Banik, Andy Lin & Eleftherios T. Papoutsakis. (2009) Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: Scale-up of a whole-cell immunotherapy product. Biotechnology and Bioengineering, pages n/a-n/a.
Crossref
Keli L. HippenPaul Harker-MurrayStephen B. PorterSarah C. MerkelAryel LonderDawn K. TaylorMegan BinaAngela Panoskaltsis-MortariPablo RubinsteinNico Van RooijenTatiana N. Golovina, Megan M. Suhoski, Jeffrey S. Miller, John E. WagnerCarl H. June, James L. Riley & Bruce R. Blazar. (2008) Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 112:7, pages 2847-2857.
Crossref
Toshiyoshi Fujiwara & Noriaki Tanaka. (2008) . Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 120:3, pages 321-327.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.